Home / Business / Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 – Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders – ResearchAndMarkets.

Business

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 – Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS Disorders – ResearchAndMarkets.

By wpadministrator

No Comments

December 19, 2025 7:32 pm

The “Central Nervous System Therapeutics Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market fo…

DUBLIN–(BUSINESS WIRE)–The “Central Nervous System Therapeutics Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Central Nervous System Therapeutics was valued at US$107 Billion i… [5223 chars]

Source: Business Wire | Published: 2025-12-19T19:32:00Z

Credit: Business Wire